A detailed history of Alpha Dna Investment Management LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Alpha Dna Investment Management LLC holds 2,092 shares of UTHR stock, worth $752,241. This represents 0.29% of its overall portfolio holdings.

Number of Shares
2,092
Previous 3,032 31.0%
Holding current value
$752,241
Previous $965,000 22.38%
% of portfolio
0.29%
Previous 0.39%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$311.04 - $363.55 $292,377 - $341,737
-940 Reduced 31.0%
2,092 $749,000
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $692,084 - $967,329
3,032 New
3,032 $965,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Alpha Dna Investment Management LLC Portfolio

Follow Alpha Dna Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Dna Investment Management LLC with notifications on news.